Literature DB >> 19959334

T lymphocytes impair P-glycoprotein function during neuroinflammation.

Gijs Kooij1, Jack van Horssen, Elizabeth C M de Lange, Arie Reijerkerk, Susanne M A van der Pol, Bert van Het Hof, Joost Drexhage, Anke Vennegoor, Joep Killestein, George Scheffer, Ruud Oerlemans, Rik Scheper, Paul van der Valk, Christine D Dijkstra, Helga E de Vries.   

Abstract

The ATP-binding cassette (ABC) transporter P-glycoprotein (P-gp; ABCB1) is highly expressed at the blood-brain barrier (BBB). P-gp actively secretes and keeps the central nervous system (CNS) safe from body-born metabolites, but also from drugs and food components, emphasising the importance of its optimal function to maintain brain homeostasis. Here we demonstrate that vascular P-gp expression and function are strongly decreased during neuroinflammation. In vivo, the expression and function of brain endothelial P-gp in experimental allergic encephalomyelitis (EAE), an animal model for multiple sclerosis (MS), were significantly impaired. Strikingly, vascular P-gp expression was decreased in both MS and EAE lesions and its disappearance coincided with the presence of perivascular infiltrates consisting of lymphocytes. Our data strongly suggest that activated CD4(+) T cells induce impaired function of brain endothelial P-gp. Notably, lymphocyte interaction through endothelial intracellular adhesion molecule -1 (ICAM-1) resulted in activation of a nuclear factor kappa B (NF-kappaB) signaling pathway, which resulted in endothelial P-gp malfunction. Our study provides first evidence that CD4(+) T cells are able to affect endogenous molecular protection mechanisms of brain endothelium. Loss of vascular P-gp function during neuroinflammation may disturb brain homeostasis and thereby aggravate disease progression via exposure of vulnerable CNS cells to detrimental compounds.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19959334     DOI: 10.1016/j.jaut.2009.10.006

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  18 in total

Review 1.  Current perspectives on the link between neuroinflammation and neurogenesis.

Authors:  Brian Wang; Kunlin Jin
Journal:  Metab Brain Dis       Date:  2014-03-13       Impact factor: 3.584

2.  Inhibition of T-cell activation attenuates hypertension, TNFα, IL-17, and blood-brain barrier permeability in pregnant rats with angiogenic imbalance.

Authors:  Cynthia Bean; Shauna-Kay Spencer; Teylor Bowles; Patrick B Kyle; Jan M Williams; Jacob Gibbens; Kedra Wallace
Journal:  Am J Reprod Immunol       Date:  2016-08-01       Impact factor: 3.886

3.  Early brain injury alters the blood-brain barrier phenotype in parallel with β-amyloid and cognitive changes in adulthood.

Authors:  Viorela Pop; Dane W Sorensen; Joel E Kamper; David O Ajao; M Paul Murphy; Elizabeth Head; Richard E Hartman; Jérôme Badaut
Journal:  J Cereb Blood Flow Metab       Date:  2012-11-14       Impact factor: 6.200

Review 4.  Age-associated physiological and pathological changes at the blood-brain barrier: A review.

Authors:  Franciska Erdő; László Denes; Elizabeth de Lange
Journal:  J Cereb Blood Flow Metab       Date:  2016-11-11       Impact factor: 6.200

Review 5.  Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders.

Authors:  Hisham Qosa; David S Miller; Piera Pasinelli; Davide Trotti
Journal:  Brain Res       Date:  2015-07-15       Impact factor: 3.252

Review 6.  Transporters as Drug Targets in Neurological Diseases.

Authors:  H Qosa; L A Mohamed; S Alqahtani; B S Abuasal; R A Hill; A Kaddoumi
Journal:  Clin Pharmacol Ther       Date:  2016-08-27       Impact factor: 6.875

7.  Inhibition of cerebral vascular inflammation by brain endothelium-targeted oligodeoxynucleotide complex.

Authors:  Jing Hu; Daniah Al-Waili; Aishlin Hassan; Guo-Chang Fan; Mei Xin; Jiukuan Hao
Journal:  Neuroscience       Date:  2016-04-27       Impact factor: 3.590

Review 8.  Identifying immune mechanisms mediating the hypertension during preeclampsia.

Authors:  Babbette LaMarca; Denise C Cornelius; Ashlyn C Harmon; Lorena M Amaral; Mark W Cunningham; Jessica L Faulkner; Kedra Wallace
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-04-20       Impact factor: 3.619

9.  Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain.

Authors:  Ronald E Cannon; John C Peart; Brian T Hawkins; Christopher R Campos; David S Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

Review 10.  Inflammatory events at blood-brain barrier in neuroinflammatory and neurodegenerative disorders: implications for clinical disease.

Authors:  Helga E de Vries; Gijs Kooij; Dan Frenkel; Spiros Georgopoulos; Alon Monsonego; Damir Janigro
Journal:  Epilepsia       Date:  2012-11       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.